de Bodinat C - Search Results

1

Agomelatine, the first melatonergic antidepressant: discovery, characterization and development.

de Bodinat C, Guardiola-Lemaitre B, Mocaër E, Renard P, Muñoz C, Millan MJ. de Bodinat C, et al. Nat Rev Drug Discov. 2010 Aug;9(8):628-42. doi: 10.1038/nrd3140. Epub 2010 Jun 25. Nat Rev Drug Discov. 2010. PMID: 20577266 Review.

2

[Development of a new antidepressant : agomelatine].

Mocaër E, Delalleau B, Boyer PA, de Bodinat C. Mocaër E, et al. Among authors: de bodinat c. Med Sci (Paris). 2005 Oct;21(10):888-93. doi: 10.1051/medsci/20052110888. Med Sci (Paris). 2005. PMID: 16197911 Review. French.

3

Efficacy of agomelatine in generalized anxiety disorder: a randomized, double-blind, placebo-controlled study.

Stein DJ, Ahokas AA, de Bodinat C. Stein DJ, et al. Among authors: de bodinat c. J Clin Psychopharmacol. 2008 Oct;28(5):561-6. doi: 10.1097/JCP.0b013e318184ff5b. J Clin Psychopharmacol. 2008. PMID: 18794654 Clinical Trial.

4

Agomelatine facilitates positive versus negative affective processing in healthy volunteer models.

Harmer CJ, de Bodinat C, Dawson GR, Dourish CT, Waldenmaier L, Adams S, Cowen PJ, Goodwin GM. Harmer CJ, et al. Among authors: de bodinat c. J Psychopharmacol. 2011 Sep;25(9):1159-67. doi: 10.1177/0269881110376689. Epub 2010 Jul 21. J Psychopharmacol. 2011. PMID: 20660010 Clinical Trial.

5

Is it time to shift to better characterization of patients in trials assessing novel antidepressants? An example of two relapse prevention studies with agomelatine.

Goodwin GM, Boyer P, Emsley R, Rouillon F, de Bodinat C. Goodwin GM, et al. Among authors: de bodinat c. Int Clin Psychopharmacol. 2013 Jan;28(1):20-8. doi: 10.1097/YIC.0b013e32835b0814. Int Clin Psychopharmacol. 2013. PMID: 23151774 Clinical Trial.

6

Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24-wk randomized, controlled, double-blind trial.

Corruble E, de Bodinat C, Belaïdi C, Goodwin GM; agomelatine study group. Corruble E, et al. Among authors: de bodinat c. Int J Neuropsychopharmacol. 2013 Nov;16(10):2219-34. doi: 10.1017/S1461145713000679. Epub 2013 Jul 3. Int J Neuropsychopharmacol. 2013. PMID: 23823799 Clinical Trial.

7

How to switch to agomelatine after an unsuccessful try with paroxetine or venlafaxine.

Lejoyeux M, Matharan S, de Bodinat C. Lejoyeux M, et al. Among authors: de bodinat c. CNS Spectr. 2015 Feb;20(1):29-38. doi: 10.1017/S1092852913000813. Epub 2013 Dec 13. CNS Spectr. 2015. PMID: 24330826 Clinical Trial.

8

A placebo-controlled study of three agomelatine dose regimens (10 mg, 25 mg, 25-50 mg) in patients with major depressive disorder.

Kennedy SH, Avedisova A, Giménez-Montesinos N, Belaïdi C, de Bodinat C; Agomelatine Study Group. Kennedy SH, et al. Among authors: de bodinat c. Eur Neuropsychopharmacol. 2014 Apr;24(4):553-63. doi: 10.1016/j.euroneuro.2014.01.006. Epub 2014 Jan 31. Eur Neuropsychopharmacol. 2014. PMID: 24530273 Clinical Trial.

9

Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties.

Guardiola-Lemaitre B, De Bodinat C, Delagrange P, Millan MJ, Munoz C, Mocaër E. Guardiola-Lemaitre B, et al. Among authors: de bodinat c. Br J Pharmacol. 2014 Aug;171(15):3604-19. doi: 10.1111/bph.12720. Br J Pharmacol. 2014. PMID: 24724693 Free PMC article. Review.

10

Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: randomised double-blind placebo-controlled trial.

Yatham LN, Vieta E, Goodwin GM, Bourin M, de Bodinat C, Laredo J, Calabrese J; Agomelatine Study Group. Yatham LN, et al. Among authors: de bodinat c. Br J Psychiatry. 2016 Jan;208(1):78-86. doi: 10.1192/bjp.bp.114.147587. Epub 2015 May 21. Br J Psychiatry. 2016. PMID: 25999335 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results